The potential role of retroviruses in autoimmunity

Immunological Reviews

Volumn 269, Issue 1, 2016, Pages 85-99

  Yu, Philipp ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Autoimmunity; Endogenous retrovirus; Innate immunity; Murine models

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; NUCLEIC ACID; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; ENDOGENOUS RETROVIRUS; GENETICS; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RETROVIRIDAE; ANIMAL; AUTOIMMUNE DISEASES; COMPLICATION; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MOUSE; RETROVIRUS INFECTION; VIRUS ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE TOLERANCE; MICE; NUCLEIC ACIDS; RECEPTORS, PATTERN RECOGNITION; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; VIRUS ACTIVATION;

EID: 84950147374     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12371     Document Type: Article

References (137)

1. Silverstein AM. Autoimmunity versus horror autotoxicus: the struggle for recognition. Nat Immunol 2001;2:279-281.
2. Linsk R, Gottesman M, Pernis B. Are tissues a patch quilt of ectopic gene expression? Science 1989;246:261.
3. Ezkurdia I, et al. Multiple evidence strands suggest that there may be as few as 19, 000 human protein-coding genes. Hum Mol Genet 2014;23:5866-5878.
4. Weiss RA. The discovery of endogenous retroviruses. Retrovirology 2006;3:67.
5. Dempsey A, Bowie AG. Innate immune recognition of DNA: a recent history. Virology 2015;479-480C:146-152.
6. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-384.
7. Kane M, Golovkina T. Realities of virus sensing. Microbes Infect 2012;14:1017-1025.
8. Dreyfus DH. Autoimmune disease: a role for new anti-viral therapies? Autoimmun Rev 2011;11:88-97.
9. Baudino L, Yoshinobu K, Morito N, Santiago-Raber ML, Izui S. Role of endogenous retroviruses in murine SLE. Autoimmun Rev 2010;10:27-34.
10. Berkhout B, Jeang KT. Retrovirus replication strategies. Curr Opin Virol 2013;3:601-603.
11. Weiss RA, Stoye JP. Virology. Our viral inheritance. Science 2013;340:820-821.
12. Koonin EV, Dolja VV, Krupovic M. Origins and evolution of viruses of eukaryotes: the ultimate modularity. Virology 2015;479-480C:2-25.
13. Aiewsakun P, Katzourakis A. Endogenous viruses: connecting recent and ancient viral evolution. Virology 2015;479-480C:26-37.
14. Hayward A, Cornwallis CK, Jern P. Pan-vertebrate comparative genomics unmasks retrovirus macroevolution. Proc Natl Acad Sci USA 2015;112:464-469.
15. Wolf D, Goff SP. Host restriction factors blocking retroviral replication. Annu Rev Genet 2008;42:143-163.
16. Hurst TP, Magiorkinis G. Activation of the innate immune response by endogenous retroviruses. J Gen Virol 2015;96:1207-1218.
17. Chiu YL, Greene WC. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 2008;26:317-353.
18. Abu-Shakra M, Shoenfeld Y. Chronic infections and autoimmunity. Immunol Ser 1991;55:285-313.
19. Karpas A. Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology. Biol Rev Camb Philos Soc 2004;79:911-933.
20. Medzhitov R, Littman D. HIV immunology needs a new direction. Nature 2008;455:591.
21. Peeters M, D'Arc M, Delaporte E. Origin and diversity of human retroviruses. AIDS Rev 2014;16:23-34.
22. Stoye JP, Moroni C, Coffin JM. Virological events leading to spontaneous AKR thymomas. J Virol 1991;65:1273-1285.
23. Kozak CA. Evolution of different antiviral strategies in wild mouse populations exposed to different gammaretroviruses. Curr Opin Virol 2013;3:657-663.
24. Dupressoir A, et al. Syncytin-A knockout mice demonstrate the critical role in placentation of a fusogenic, endogenous retrovirus-derived, envelope gene. Proc Natl Acad Sci USA 2009;106:12127-12132.
25. Stoye JP. Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol 2012;10:395-406.
26. Al Hussaini M, Hammouda EI, Hammouda AE. Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role. Int J Clin Pharm 2014;36:684-692.
27. Nakagawa K, Harrison LC. The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 1996;152:193-236.
28. Pelton BK, et al. A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 1988;47:206-209.
29. Iordache L, et al. Autoimmune diseases in HIV-infected patients: 52 cases and literature review. Autoimmun Rev 2014;13:850-857.
30. Mody GM, Patel N, Budhoo A, Dubula T. Concomitant systemic lupus erythematosus and HIV: case series and literature review. Semin Arthritis Rheum 2014;44:186-194.
31. Bailer RT, et al. Lack of evidence for human T cell lymphotrophic virus type I or II infection in patients with systemic lupus erythematosus or rheumatoid arthritis. J Rheumatol 1994;21:2217-2224.
32. Levin MC, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002;8:509-513.
33. Walsh ER, et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc Natl Acad Sci USA 2012;109:16276-16281.
34. Mandl JN, et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008;14:1077-1087.
35. Vincendeau M, et al. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection. Retrovirology 2015;12:27.
36. Laderoute MP, et al. The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia. AIDS 2007;21:2417-2424.
37. Garrison KE, et al. T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS Pathog 2007;3:e165.
38. Contreras-Galindo R, et al. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. J Virol 2012;86:262-276.
39. van der Kuyl AC. HIV infection and HERV expression: a review. Retrovirology 2012;9:6.
40. Liu M, et al. Polyreactivity and autoreactivity among HIV-1 antibodies. J Virol 2015;89:784-798.
41. Bonsignori M, et al. An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1. J Clin Invest 2014;124:1835-1843.
42. Balada E, Vilardell-Tarres M, Ordi-Ros J. Implication of human endogenous retroviruses in the development of autoimmune diseases. Int Rev Immunol 2010;29:351-370.
43. Nexo BA, et al. The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1. PLoS ONE 2011;6:e16652.
44. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997;90:303-313.
45. Nelson PN, et al. Rheumatoid arthritis is associated with IgG antibodies to human endogenous retrovirus gag matrix: a potential pathogenic mechanism of disease? J Rheumatol 2014;41:1952-1960.
46. Nelson P, Rylance P, Roden D, Trela M, Tugnet N. Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus 2014;23:596-605.
47. Kalden JR, Winkler TH, Herrmann M, Krapf F. Pathogenesis of SLE: immunopathology in man. Rheumatol Int 1991;11:95-100.
48. Brudek T, Christensen T, Hansen HJ, Bobecka J, Moller-Larsen A. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res Hum Retroviruses 2004;20:415-423.
49. Derfuss T, et al. A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. Mult Scler 2015;21:885-893.
50. Perron H, et al. Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice. PLoS ONE 2013;8:e80128.
51. Bannert N, Kurth R. The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet 2006;7:149-173.
52. Bieda K, Hoffmann A, Boller K. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J Gen Virol 2001;82:591-596.
53. Dewannieux M, et al. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res 2006;16:1548-1556.
54. Contreras-Galindo R, et al. Human endogenous retrovirus type K (HERV-K) particles package and transmit HERV-K-related sequences. J Virol 2015;89:7187-7201.
55. Schlesinger S, Goff SP. Retroviral transcriptional regulation and embryonic stem cells: war and peace. Mol Cell Biol 2015;35:770-777.
56. Maricato JT, et al. Epigenetic modulations in activated cells early after HIV-1 infection and their possible functional consequences. PLoS ONE 2015;10:e0119234.
57. Nishitsuji H, Sawada L, Sugiyama R, Takaku H. ZNF10 inhibits HIV-1 LTR activity through interaction with NF-kappaB and Sp1 binding motifs. FEBS Lett 2015;589:2019-2025.
58. Matsui T, et al. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 2010;464:927-931.
59. Grow EJ, et al. Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature 2015;522:221-225.
60. Kane M, Case LK, Wang C, Yurkovetskiy L, Dikiy S, Golovkina TV. Innate immune sensing of retroviral infection via Toll-like receptor 7 occurs upon viral entry. Immunity 2011;35:135-145.
61. Volkman HE, Stetson DB. The enemy within: endogenous retroelements and autoimmune disease. Nat Immunol 2014;15:415-422.
62. Shlomchik MJ. Activating systemic autoimmunity: B's, T's, and tolls. Curr Opin Immunol 2009;21:626-633.
63. Tsumiyama K, Miyazaki Y, Shiozawa S. Self-organized criticality theory of autoimmunity. PLoS ONE 2009;4:e8382.
64. Risser R, Horowitz JM, McCubrey J. Endogenous mouse leukemia viruses. Annu Rev Genet 1983;17:85-121.
65. Rein A. Murine leukemia viruses: objects and organisms. Adv Virol 2011;2011:403419.
66. Stocking C, Kozak CA. Murine endogenous retroviruses. Cell Mol Life Sci 2008;65:3383-3398.
67. Pedersen FS, Crowther RL, Tenney DY, Reimold AM, Haseltine WA. Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour. Nature 1981;292:167-170.
68. Pollard KM, Pearson DL, Hultman P, Hildebrandt B, Kono DH. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ Health Perspect 1999;107(Suppl):729-735.
69. Gaudet F, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003;300:489-492.
70. Howard G, Eiges R, Gaudet F, Jaenisch R, Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 2008;27:404-408.
71. Rowe HM, Trono D. Dynamic control of endogenous retroviruses during development. Virology 2011;411:273-287.
72. Haywood ME, Gabriel L, Rose SJ, Rogers NJ, Izui S, Morley BJ. BXSB/long-lived is a recombinant inbred strain containing powerful disease suppressor loci. J Immunol 2007;179:2428-2434.
73. Subramanian S, et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 2006;103:9970-9975.
74. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006;312:1669-1672.
75. Andrews BS, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-1215.
76. Santiago-Raber ML, et al. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol 2008;181:1556-1562.
77. Levy JA, Pincus T. Demonstration of biological activity of a murine leukemia virus of New Zealand black mice. Science 1970;170:326-327.
78. Eilat D, Wabl M. B cell tolerance and positive selection in lupus. J Immunol 2012;189:503-509.
79. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002;99:2281-2286.
80. Beck-Engeser GB, Eilat D, Harrer T, Jack HM, Wabl M. Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir. Proc Natl Acad Sci USA 2009;106:20865-20870.
81. Beck-Engeser GB, Eilat D, Wabl M. An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 2011;8:91.
82. Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008;134:587-598.
83. Funabiki M, et al. Autoimmune disorders associated with gain of function of the intracellular sensor MDA5. Immunity 2014;40:199-212.
84. Young GR, Eksmond U, Salcedo R, Alexopoulou L, Stoye JP, Kassiotis G. Resurrection of endogenous retroviruses in antibody-deficient mice. Nature 2012;491:774-778.
85. Kwon DN, Lee YK, Greenhalgh DG, Cho K. Lipopolysaccharide stress induces cell-type specific production of murine leukemia virus type-endogenous retroviral virions in primary lymphoid cells. J Gen Virol 2011;92:292-300.
86. Yu P, et al. Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity 2012;37:867-879.
87. Aaronson SA, Stephenson JR. Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus. Proc Natl Acad Sci USA 1974;71:1957-1961.
88. Rigby RE, et al. RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J 2014;33:542-558.
89. Ohto U, et al. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature 2015;520:702-705.
90. Browne EP. Toll-like receptor 7 controls the anti-retroviral germinal center response. PLoS Pathog 2011;7:e1002293.
91. Browne EP, Littman DR. Myd88 is required for an antibody response to retroviral infection. PLoS Pathog 2009;5:e1000298.
92. Browne EP. Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responses. J Virol 2013;87:7357-7366.
93. Heil F, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-1529.
94. Dominguez-Villar M, Gautron AS, de Marcken M, Keller MJ, Hafler DA. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol 2015;16:118-128.
95. Lepelley A, et al. Innate sensing of HIV-infected cells. PLoS Pathog 2011;7:e1001284.
96. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004;303:1529-1531.
97. Gentile F, Deriu MA, Licandro G, Prunotto A, Danani A, Tuszynski JA. Structure based modeling of small molecules binding to the TLR7 by atomistic level simulations. Molecules 2015;20:8316-8340.
98. Tanji H, Ohto U, Shibata T, Miyake K, Shimizu T. Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science 2013;339:1426-1429.
99. Kanno A, et al. Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases. Nat Commun 2015;6:6119.
100. Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005;23:165-175.
101. Tluk S, et al. Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses. Int Immunol 2009;21:607-619.
102. Vollmer J, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005;202:1575-1585.
103. Kaiser S, Rimbach K, Eigenbrod T, Dalpke AH, Helm M. A modified dinucleotide motif specifies tRNA recognition by TLR7. RNA 2014;20:1351-1355.
104. Hornung V, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005;11:263-270.
105. Nundel K, et al. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses. J Immunol 2015;194:2504-2512.
106. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006;25:417-428.
107. Desnues B, et al. TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice. Proc Natl Acad Sci USA 2014;111:1497-1502.
108. Deane JA, et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007;27:801-810.
109. Giltiay NV, et al. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J Exp Med 2013;210:2773-2789.
110. Guiducci C, et al. RNA recognition by human TLR8 can lead to autoimmune inflammation. J Exp Med 2013;210:2903-2919.
111. Forsbach A, et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J Immunol 2008;180:3729-3738.
112. Gorden KK, Qiu XX, Binsfeld CC, Vasilakos JP, Alkan SS. Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. J Immunol 2006;177:6584-6587.
113. Tran NL, Manzin-Lorenzi C, Santiago-Raber ML. Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism. Immunology 2015;145:60-70.
114. Boneparth A, et al. TLR7 influences germinal center selection in murine SLE. PLoS ONE 2015;10:e0119925.
115. 2+ entry. Immunity 2005;22:451-465.
116. Jacob M, Napirei M, Ricken A, Dixkens C, Mannherz HG. Histopathology of lupus-like nephritis in Dnase1-deficient mice in comparison to NZB/W F1 mice. Lupus 2002;11:514-527.
117. Baum R, et al. Cutting edge: AIM2 and endosomal TLRs differentially regulate arthritis and autoantibody production in DNase II-deficient mice. J Immunol 2015;194:873-877.
118. Takaoka A, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007;448:501-505.
119. Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013;339:786-791.
120. Ablasser A, Hemmerling I, Schmid-Burgk JL, Behrendt R, Roers A, Hornung V. TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J Immunol 2014;192:5993-5997.
121. Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat Immunol 2012;13:214-222.
122. Yan N, Lieberman J. Gaining a foothold: how HIV avoids innate immune recognition. Curr Opin Immunol 2011;23:21-28.
123. Ahn J, Ruiz P, Barber GN. Intrinsic self-DNA triggers inflammatory disease dependent on STING. J Immunol 2014;193:4634-4642.
124. Zeng M, et al. MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses. Science 2014;346:1486-1492.
125. Maksakova IA, Romanish MT, Gagnier L, Dunn CA, van de Lagemaat LN, Mager DL. Retroviral elements and their hosts: insertional mutagenesis in the mouse germ line. PLoS Genet 2006;2:e2.
126. Imahashi M, Nakashima M, Iwatani Y. Antiviral mechanism and biochemical basis of the human APOBEC3 family. Front Microbiol 2012;3:250.
127. Beck-Engeser GB, et al. APOBEC3 enzymes restrict marginal zone B cells. Eur J Immunol 2015;45:695-704.
128. Rowe WP, Kozak CA. Germ-line reinsertions of AKR murine leukemia virus genomes in Akv-1 congenic mice. Proc Natl Acad Sci USA 1980;77:4871-4874.
129. Pear WS, Aster JC. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 2004;11:426-433.
130. Meffre E, Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol 2008;20:632-638.
131. Cantrell D. Signaling in lymphocyte activation. Cold Spring Harbor Perspect Biol 2015;7:1-14.
132. Wu J, Zhou T, He J, Mountz JD. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 1993;178:461-468.
133. Chu JL, Drappa J, Parnassa A, Elkon KB. The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 1993;178:723-730.
134. Bernatsky S, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun 2013;42:130-135.
135. Oldstone MB, Aoki T, Dixon FJ. The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci USA 1972;69:134-138.
136. Boros P, Chen JM, Bona C, Unkeless JC. Autoimmune mice make anti-Fc gamma receptor antibodies. J Exp Med 1990;171:1581-1595.
137. Pawaria S, et al. Cutting edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands. J Immunol 2015;194:1403-1407.